NCT03077750View on ClinicalTrials.gov

A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

March 30, 2018

Study Completion Date

April 27, 2018

Conditions
Molluscum Contagiosum
Interventions
DRUG

VBP-245 Topical Gel

Topical application BID

DRUG

Vehicle

Vehicle Control With No Active Pharmaceutical Ingredients

Trial Locations (3)

19034

Philadelphia Institute of Dermatology, Fort Washington

29464

Coastal Pediatrics, Mt. Pleasant

29607

Parkside Pediatrics, Greenville

All Listed Sponsors
lead

Veloce BioPharma LLC

INDUSTRY

NCT03077750 - A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum | Biotech Hunter | Biotech Hunter